{
    "1682382506216103943": {
        "attachments": {
            "media_keys": [
                "13_1682382420975185923"
            ]
        },
        "author_id": "62465691",
        "created_at": "2023-07-21T13:30:21.000Z",
        "edit_history_tweet_ids": [
            "1682382506216103943"
        ],
        "entities": {
            "annotations": [
                {
                    "end": 31,
                    "normalized_text": "RSV",
                    "probability": 0.4602,
                    "start": 29,
                    "type": "Other"
                },
                {
                    "end": 40,
                    "normalized_text": "disease",
                    "probability": 0.4938,
                    "start": 34,
                    "type": "Other"
                },
                {
                    "end": 126,
                    "normalized_text": "RSV",
                    "probability": 0.549,
                    "start": 124,
                    "type": "Other"
                }
            ],
            "urls": [
                {
                    "description": "Respiratory syncytial virus in infants, including those high-risk, are a priority to protect. Learn to identify early signs and symptoms of RSV.",
                    "display_url": "learn.az/6016PrsPw",
                    "end": 216,
                    "expanded_url": "https://learn.az/6016PrsPw",
                    "start": 193,
                    "status": 200,
                    "title": "Our ambition to improve RSV care for infants",
                    "unwound_url": "https://www.astrazeneca.com/our-therapy-areas/vaccines-and-immune-therapies/respiratory-syncytial-virus.html?utm_source=twitter&utm_medium=nirsevimab+us+milestones+social+media+calendar&utm_term=11960&utm_content=r%2526i",
                    "url": "https://t.co/u12ALiUrS4"
                },
                {
                    "display_url": "pic.twitter.com/xGkVEPhUpY",
                    "end": 240,
                    "expanded_url": "https://twitter.com/AstraZeneca/status/1682382506216103943/video/1",
                    "media_key": "13_1682382420975185923",
                    "start": 217,
                    "url": "https://t.co/xGkVEPhUpY"
                }
            ]
        },
        "id": "1682382506216103943",
        "lang": "en",
        "public_metrics": {
            "bookmark_count": 0,
            "impression_count": 5616,
            "like_count": 16,
            "quote_count": 0,
            "reply_count": 4,
            "retweet_count": 5
        },
        "text": "Respiratory syncytial virus (RSV) disease is a serious health threat to infants. \n\nLearn more about our efforts to innovate RSV care for all infants from this serious respiratory illness here: https://t.co/u12ALiUrS4 https://t.co/xGkVEPhUpY"
    }
}